Clariane Listed on Euronext Paris and SBF 120 Index

Clariane, a leading healthcare company, announced its listing on Euronext Paris, Section B on November 2006. As of September 23, 2024, the company’s stock has joined the SBF 120 index and the CAC® SBT 1.5° index, underscoring its commitment to sustainable and responsible business practices.

Clariane’s corporate purpose is "taking care of each person's humanity in times of vulnerability," a mission that guides its operations in two major areas: long-term care and specialty care. The company provides care and support to over 840,000 residents and patients annually through its networks of medicalized nursing homes and alternative living solutions, as well as through its specialty care activities including medical, post-acute, and rehabilitation services, and mental health services.

Headquartered in France, Clariane operates under the Clariane Group, which includes subsidiaries such as Korian, Âges & Vie, and Rosorum for long-term care, and Inicea, Kormed, Iterias, and Grupo 5 for specialty care. The company’s listing on Euronext Paris is a significant milestone, reflecting its strong financial performance and commitment to sustainable growth.

Clariane’s inclusion in the SBF 120 index, known for its focus on the French stock market, highlights the company’s robust financial health and market recognition. The addition to the CAC® SBT 1.5° index, which measures companies' contributions to the fight against climate change, is a testament to Clariane’s dedication to environmental sustainability and corporate social responsibility.

With a workforce of 70,000 professionals, Clariane continues to expand its services, ensuring that it meets the growing needs of an aging population and those with special healthcare requirements. The company’s listing on Euronext Paris and its inclusion in these significant indices are expected to attract increased investor interest, further solidifying its position as a leading provider of healthcare services in France and beyond.